Healthcare Providers and Services
Company Overview of Kennedy Krieger Institute Inc.
Kennedy Krieger Institute Inc. provides services to improve the lives of children and adolescents with brain, spinal cord and musculoskeletal disorders through patient care, special education, research, and professional training. The company offers outpatient clinic, neurobehavioral, rehabilitation, and pediatric feeding disorders inpatient services, as well as home and community programs to assist families. It also provides training services for specialists in the United States and internationally. Kennedy Krieger Institute Inc. was formerly known as Kennedy Institute and changed its name to Kennedy Krieger Institute Inc. in 1992. The company was founded in 1937 and is based in Baltimore, M...
707 North Broadway
Baltimore, MD 21205
Founded in 1937
Key Executives for Kennedy Krieger Institute Inc.
Senior Vice President of Nursing & Patient Services and Director of Nursing Department
Assistant Vice President of Development
Director of Spinal Cord Research Center
Compensation as of Fiscal Year 2016.
Kennedy Krieger Institute Inc. Key Developments
Kennedy Krieger Institute and Viking Therapeutics, Inc. Sign Research Collaboration Agreement
Nov 23 15
Kennedy Krieger Institute and Viking Therapeutics, Inc. announced research collaboration focused on evaluating the company's novel thyroid beta agonists for the treatment of X-linked adrenoleukodystrophy (X-ALD). Under terms of the agreement, Kennedy Krieger's X-ALD research scientists will study Viking's proprietary thyroid beta agonists, including VK0214, in vivo models of X-ALD. This research will build upon previous cell-based data demonstrating that the company's thyroid beta agonists positively affect the expression of specific genes relevant to X-ALD. In the planned work, researchers at the Kennedy Krieger will utilize an in vivo X-ALD model to assess the impact of VK0214 on key biomarkers of the disease. The successful completion of this work will support Viking's initiation of IND-enabling activities with the goal of advancing VK0214 into clinical studies.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries